Home

Utrogestan (micronised progesterone) 100mg is indicated for adjunctive use with oestrogen in postmenopausal women with an intact uterus, as hormone replacement therapy (HRT).1 Educational Series
Request a visit from a Besins Healthcare Representative
Watch video educational series
Request your Utrogestan 100mg patient pad
Request your HRT Products leave piece
Feedback Survey
Why prescribe micronised progesterone and transdermal oestrogen in your postmenopausal patients?
The importance of body identical in HRT
The latest guidance recommendations for selecting a suitable HRT for postmenopausal women
Please accept marketing-cookies to watch this video.

Why prescribe micronised progesterone and transdermal oestrogen in your postmenopausal patients?

Presented by
Dr Jane F Wilkinson

NHS General Practitioner, British Menopause Society-accredited Menopause Specialist, GP Champion for Sexual Health, Wirral & Clinical Director of Menopause Wellbeing.

Duration 7:24

Please accept marketing-cookies to watch this video.

The importance of body identical in HRT

Presented by
Dr Nick Panay

Consultant Gynaecologist and Director of the West London Menopause & PMS Centre Queen Charlotte’s & Chelsea Hospital and Chelsea & Westminster Hospital London and Director of International Centre for Hormone Health.

Duration 7:08

Please accept marketing-cookies to watch this video.

The latest guidance recommendations for selecting a suitable HRT for postmenopausal women

Presented by
Dr Shahzadi Harper

General Practitioner, menopause doctor and founder of the Harper Clinic.

Duration 4:52

Please consult the Summary of Product Characteristics for a full list of Warnings, Precautions & Contraindications before prescribing Utrogestan 100mg.1

To view Oestrogel (estradiol) Prescribing Information please click here

Prescribing Information

For further information on Oestrogel please click here

Oestrogel website

    REQUEST MORE
    INFORMATION ON UTROGESTAN 100MG

    * Required field

    Besins Healthcare (UK) Ltd would like to request your consent for the company to use your email address to send information to you on the subject areas listed below. Please indicate your consent preference below.

    I agree to receiving information by email on the following topics:

    For example, an appointment request from a key account manager, information about the safety and effectiveness of our medicines, educational support for healthcare professionals and patients associated with our products.

    For example, educational events on the management of conditions associated with our medicine

    By clicking any of the above, you agree to Besins Healthcare terms of service and privacy policy.

    If you wish to amend or remove the consent you have selected above in the future, please email DataPrivacyUK@besins-healthcare.com.

    References:

    1. Utrogestan Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/product/352/smpc Last accessed: April 2021.